NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/23/2025
Back to search
Official data from USPTO
QUBALYN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
05/24/2025
Trademark type
Word
Nice classes
5
Filing date
01/13/2020
Registration date
10/06/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/06/2020
Last transaction
05/24/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
CARR,PATRICK C
Law office
N70
Current location
POST REGISTRATION
Holders and representatives
Holders
Glaxo Group Limited
Representatives
Legal Brand Protection, GSK Legal Brand Protection, GSK
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; * blood disorderspaininflammationsepsisalopeciaobesity and cognitive disordersexcept pharmaceutical preparations and substances to treat infectious diseases and dermatology products * ; pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; vaccines; * except pharmaceutical preparations and substances to treat infectious diseases and dermatology products vaccinesexcept vaccines to treat infectious diseases *
Publications
History of USPTO decisions and trademark events.
23 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/11/2023
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
05/06/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/04/2022
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/04/2021
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
03/29/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
03/28/2021
GPNX
NOTIFICATION PROCESSED BY IB
12/05/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/18/2020
FIMP
FINAL DISPOSITION PROCESSED
11/18/2020
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
11/05/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/01/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
10/06/2020
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
08/30/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/20/2020
PUBO
PUBLISHED FOR OPPOSITION
04/21/2020
NPUB
NOTICE OF PUBLICATION
04/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/19/2020
DOCK
ASSIGNED TO EXAMINER
03/15/2020
MAFR
APPLICATION FILING RECEIPT MAILED
03/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/04/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
03/02/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/27/2020
Continuous trademark protection
Get notified about every new filing that threatens QUBALYN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.